Commercializing the Academic Research – and Managing Substantial Growth

The Science of Talent by BioTalent Canada

Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that.

Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model is working, with growth forecast to see 60 staff currently blossom to 150 in the next 18 months.

In addition, the Government of Canada recently made an $80.5 million investment in a key project API is involved in.

But that success itself brings many challenges. How is API handling those?

Guest: Andrew MacIsaac, CEO Applied Pharmaceutical Innovation (API)

Website: appliedpharma.ca

LinkedIn: https://www.linkedin.com/company/applied-pharmaceutical-innovation

Twitter: @api_applied

BioTalent Canada Website

See the latest news on our website

Contact

BioTalent Canada by email